Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Apr 28, 2026, 4:00 PM EDT
1.167
+0.007 (0.63%)
After-hours: Apr 28, 2026, 7:46 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.32 million as of April 28, 2026. Its market cap has increased by 49.92% in one year.
Market Cap
4.32M
Enterprise Value
-5.70M
1-Year Change
49.92%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.32M, a decrease of -95.23%. That is a compound annual growth rate of -42.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 4.99M |
| Pulmatrix | 4.93M |
| 60 Degrees Pharmaceuticals | 4.30M |
| VivoSim Labs | 4.23M |
| Alzamend Neuro | 4.22M |
| AIM ImmunoTech | 4.21M |
| Galmed Pharmaceuticals | 4.13M |
| Matinas BioPharma Holdings | 3.91M |